Sustained virologic response in DAA-treated HCV patients on anti-epileptic drugs

J Hepatol. 2023 Sep;79(3):e121-e123. doi: 10.1016/j.jhep.2023.05.018. Epub 2023 Jun 2.
No abstract available

Keywords: Anti-epileptic drugs; Direct-acting antivirals; Glecaprevir/pibrentasvir; Hepatitis C virus; Sofosbuvir/velpatasvir.

Publication types

  • Letter

MeSH terms

  • Antiviral Agents* / therapeutic use
  • Benzimidazoles / therapeutic use
  • Genotype
  • Hepacivirus / genetics
  • Hepatitis C* / drug therapy
  • Humans
  • Quinoxalines / adverse effects
  • Sofosbuvir / therapeutic use
  • Sustained Virologic Response

Substances

  • Antiviral Agents
  • Sofosbuvir
  • Benzimidazoles
  • Quinoxalines